Ofatumumab - PDFSEARCH.IO - Document Search Engine

Ofatumumab
Results: 36

#	Item
21	ISF35 Active Immunotherapy for Blood Cancer Intranodal Studies National Institutes of Health (NIH) Office of Biotechnology Activities Recombinant DNA Advisory Committee 121st Meeting Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 14:03:08 Organophosphates Purines Medicine Ofatumumab Rituximab Leukemia CD154 CD40 Bystander effect Chemistry Fludarabine Organofluorides
22	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:32:16 CD20 Immunotherapy Cancer immunotherapy Ofatumumab Medicine Lymphoma Mantle cell lymphoma
23	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:45 CD20 Immunotherapy Cancer immunotherapy Ofatumumab Medicine Lymphoma Mantle cell lymphoma
24	表4 1／25 Current as Fiscal Add to Reading List Source URL: www.nibio.go.jp Language: English - Date: 2014-03-06 20:52:23 Vaccines Influenza vaccine Transmission and infection of H5N1 Novartis Doxorubicin Ofatumumab Chugai Pharmaceutical Co. Astellas Pharma Busulfan Medicine Influenza Vaccination
25	Arzerra II-27 Final DHPC and communication plan Add to Reading List Source URL: www.mhra.gov.uk Language: English - Date: 2014-07-31 09:55:30 Cytokine release syndrome Health Hepatitis B Alemtuzumab Medicine Ofatumumab B-cell chronic lymphocytic leukemia
26	PDF Document Add to Reading List Source URL: www.gsk-korea.co.kr Language: English - Date: 2008-11-09 19:06:03 Biology Aromatic amines Oncogenes Angiology Protein kinase inhibitor Pazopanib Epidermal growth factor receptor Lapatinib Ofatumumab Chemistry Organic chemistry Tyrosine kinase receptors
27	Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) Safety Announcement[removed]The U.S. F Add to Reading List Source URL: www.fda.gov Language: English HBsAg Microbiology Rituximab Biology Hepatitis Jade Ribbon Campaign Hepatitis B in China Medicine Hepatitis B Viruses
28	Microsoft Word - Arzerra Data Backgrounder_FINAL Add to Reading List Source URL: us.gsk.com Language: English Ofatumumab B-cell chronic lymphocytic leukemia Alemtuzumab Chlorambucil Genmab CD20 Leukemia HBsAg Hepatitis B Medicine Chemistry Oncology
29	HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. • Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-09-27 15:15:31 Viruses HBsAg Alemtuzumab Ofatumumab Infusion pump Rituximab Nitazoxanide Medicine Pharmacology Hepatitis B
30	First Quarter Results Period Ended March 31, 2014 Add to Reading List Source URL: files.shareholder.com Language: English Financial ratio Financial statements Income statement Ofatumumab

UPDATE